Patents by Inventor Robert I. Goldfarb

Robert I. Goldfarb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE
    Publication number: 20150072001
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: March 10, 2014
    Publication date: March 12, 2015
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 8668931
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: May 8, 2013
    Date of Patent: March 11, 2014
    Assignee: Actavis, Inc.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE
    Publication number: 20130266647
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: May 8, 2013
    Publication date: October 10, 2013
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 8470368
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: June 2, 2011
    Date of Patent: June 25, 2013
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 8309125
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: July 14, 2010
    Date of Patent: November 13, 2012
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Unchalee Kositprapa, Avinash Nangia, John Cardinal, Robert I. Goldfarb
  • ANTIVIRAL COMPOSITONS
    Publication number: 20120201883
    Abstract: A composition which includes a carboxamide, preferably ribavirin, for treating viral diseases in humans. A preferred embodiment of the subject invention comprises a very high dose (>600 mg) of ribavirin, and more preferably between about 800-1200 mg of ribavirin or more per dosage form.
    Type: Application
    Filed: December 9, 2010
    Publication date: August 9, 2012
    Applicant: ACCU-BREAK Technologies, Inc
    Inventors: Elliot Hahn, Robert I. Goldfarb, Lawrence Solomon, Allan S. Kaplan
  • NOVEL PHARMACEUTICAL FORMULATION CONTAINING A BIGUANIDE AND A THIAZOLIDINEDIONE DERIVATIVE
    Publication number: 20110262538
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: June 2, 2011
    Publication date: October 27, 2011
    Applicant: WATSON PHARMACEUTICALS, INC.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 7959946
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: June 14, 2011
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Novel Pharmaceutical Formulation Containing A Biguanide and a Thiazolidinedione Derivative
    Publication number: 20100316708
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: July 14, 2010
    Publication date: December 16, 2010
    Inventors: Unchalee Kositprapa, Avinash Nangia, John Cardinal, Robert I. Goldfarb
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 7785627
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: September 19, 2003
    Date of Patent: August 31, 2010
    Assignee: Watson Pharmaceuticals, Inc.
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John Cardinal, Avinash Nangia
  • Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Publication number: 20040161462
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: February 12, 2004
    Publication date: August 19, 2004
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John R. Cardinal, Avinash Nangia
  • Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Publication number: 20040106660
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: September 19, 2003
    Publication date: June 3, 2004
    Inventors: Unchalee Kositprapa, Robert I. Goldfarb, John Cardinal, Avinash Nangia